nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—ovarian cancer	0.352	1	CbGaD
Propafenone—ABCB1—Topotecan—ovarian cancer	0.0546	0.15	CbGbCtD
Propafenone—CYP2C8—Paclitaxel—ovarian cancer	0.04	0.11	CbGbCtD
Propafenone—ABCB1—Vinorelbine—ovarian cancer	0.0385	0.106	CbGbCtD
Propafenone—CYP2D6—Vinorelbine—ovarian cancer	0.0363	0.0995	CbGbCtD
Propafenone—CYP3A4—Topotecan—ovarian cancer	0.0327	0.0898	CbGbCtD
Propafenone—CYP2C9—Paclitaxel—ovarian cancer	0.0279	0.0764	CbGbCtD
Propafenone—ABCB1—Paclitaxel—ovarian cancer	0.027	0.0742	CbGbCtD
Propafenone—CYP3A4—Vinorelbine—ovarian cancer	0.0231	0.0633	CbGbCtD
Propafenone—ABCB1—Docetaxel—ovarian cancer	0.0196	0.0536	CbGbCtD
Propafenone—CYP3A4—Paclitaxel—ovarian cancer	0.0162	0.0444	CbGbCtD
Propafenone—ABCB1—Doxorubicin—ovarian cancer	0.0146	0.04	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—ovarian cancer	0.0137	0.0377	CbGbCtD
Propafenone—CYP3A4—Docetaxel—ovarian cancer	0.0117	0.0321	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—ovarian cancer	0.00873	0.024	CbGbCtD
Propafenone—Carvedilol—VEGFA—ovarian cancer	0.000653	0.431	CrCbGaD
Propafenone—Mirabegron—ABCB1—ovarian cancer	0.000417	0.275	CrCbGaD
Propafenone—Carvedilol—ABCB1—ovarian cancer	0.000168	0.11	CrCbGaD
Propafenone—Fentanyl—ABCB1—ovarian cancer	0.000153	0.101	CrCbGaD
Propafenone—Myalgia—Docetaxel—ovarian cancer	0.000142	0.000504	CcSEcCtD
Propafenone—Chest pain—Docetaxel—ovarian cancer	0.000142	0.000504	CcSEcCtD
Propafenone—Nausea—Vinorelbine—ovarian cancer	0.000142	0.000504	CcSEcCtD
Propafenone—Renal failure—Epirubicin—ovarian cancer	0.000142	0.000503	CcSEcCtD
Propafenone—Dyspepsia—Paclitaxel—ovarian cancer	0.000142	0.000502	CcSEcCtD
Propafenone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000142	0.000501	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000141	0.000501	CcSEcCtD
Propafenone—Stomatitis—Epirubicin—ovarian cancer	0.000141	0.000498	CcSEcCtD
Propafenone—Jaundice—Epirubicin—ovarian cancer	0.000141	0.000498	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—ovarian cancer	0.00014	0.000496	CcSEcCtD
Propafenone—Decreased appetite—Paclitaxel—ovarian cancer	0.00014	0.000496	CcSEcCtD
Propafenone—Dry mouth—Docetaxel—ovarian cancer	0.000139	0.000493	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000139	0.000493	CcSEcCtD
Propafenone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000139	0.000492	CcSEcCtD
Propafenone—Fatigue—Paclitaxel—ovarian cancer	0.000139	0.000492	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—ovarian cancer	0.000138	0.00049	CcSEcCtD
Propafenone—Constipation—Paclitaxel—ovarian cancer	0.000138	0.000488	CcSEcCtD
Propafenone—Pain—Paclitaxel—ovarian cancer	0.000138	0.000488	CcSEcCtD
Propafenone—Haematuria—Epirubicin—ovarian cancer	0.000138	0.000488	CcSEcCtD
Propafenone—Confusional state—Docetaxel—ovarian cancer	0.000138	0.000487	CcSEcCtD
Propafenone—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000137	0.000484	CcSEcCtD
Propafenone—Oedema—Docetaxel—ovarian cancer	0.000137	0.000483	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—ovarian cancer	0.000136	0.000483	CcSEcCtD
Propafenone—Epistaxis—Epirubicin—ovarian cancer	0.000136	0.000482	CcSEcCtD
Propafenone—Infection—Docetaxel—ovarian cancer	0.000136	0.00048	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—ovarian cancer	0.000136	0.00048	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000135	0.000479	CcSEcCtD
Propafenone—Agranulocytosis—Epirubicin—ovarian cancer	0.000135	0.000477	CcSEcCtD
Propafenone—Shock—Docetaxel—ovarian cancer	0.000134	0.000476	CcSEcCtD
Propafenone—Nervous system disorder—Docetaxel—ovarian cancer	0.000134	0.000474	CcSEcCtD
Propafenone—Thrombocytopenia—Docetaxel—ovarian cancer	0.000134	0.000473	CcSEcCtD
Propafenone—Infestation—Doxorubicin—ovarian cancer	0.000134	0.000473	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—ovarian cancer	0.000134	0.000473	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—ovarian cancer	0.000134	0.000473	CcSEcCtD
Propafenone—Tachycardia—Docetaxel—ovarian cancer	0.000133	0.000472	CcSEcCtD
Propafenone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000133	0.00047	CcSEcCtD
Propafenone—Skin disorder—Docetaxel—ovarian cancer	0.000133	0.00047	CcSEcCtD
Propafenone—Bradycardia—Epirubicin—ovarian cancer	0.000132	0.000467	CcSEcCtD
Propafenone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000132	0.000466	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—ovarian cancer	0.000131	0.000465	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000131	0.000464	CcSEcCtD
Propafenone—Haemoglobin—Epirubicin—ovarian cancer	0.00013	0.000461	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—ovarian cancer	0.00013	0.000461	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—ovarian cancer	0.00013	0.000461	CcSEcCtD
Propafenone—Anorexia—Docetaxel—ovarian cancer	0.00013	0.000461	CcSEcCtD
Propafenone—Rhinitis—Epirubicin—ovarian cancer	0.00013	0.00046	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—ovarian cancer	0.00013	0.000459	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—ovarian cancer	0.00013	0.000459	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—ovarian cancer	0.000129	0.000457	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000128	0.000453	CcSEcCtD
Propafenone—Urticaria—Paclitaxel—ovarian cancer	0.000128	0.000453	CcSEcCtD
Propafenone—Hypotension—Docetaxel—ovarian cancer	0.000128	0.000452	CcSEcCtD
Propafenone—Propranolol—ABCB1—ovarian cancer	0.000127	0.084	CrCbGaD
Propafenone—Haematuria—Doxorubicin—ovarian cancer	0.000127	0.000451	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000127	0.000451	CcSEcCtD
Propafenone—Abdominal pain—Paclitaxel—ovarian cancer	0.000127	0.000451	CcSEcCtD
Propafenone—Body temperature increased—Paclitaxel—ovarian cancer	0.000127	0.000451	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—ovarian cancer	0.000127	0.00045	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000126	0.000447	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—ovarian cancer	0.000126	0.000446	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—ovarian cancer	0.000125	0.000442	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—ovarian cancer	0.000125	0.000442	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000124	0.00044	CcSEcCtD
Propafenone—Insomnia—Docetaxel—ovarian cancer	0.000123	0.000437	CcSEcCtD
Propafenone—Paraesthesia—Docetaxel—ovarian cancer	0.000123	0.000434	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—ovarian cancer	0.000122	0.000432	CcSEcCtD
Propafenone—Dyspnoea—Docetaxel—ovarian cancer	0.000122	0.000431	CcSEcCtD
Propafenone—Somnolence—Docetaxel—ovarian cancer	0.000121	0.00043	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—ovarian cancer	0.000121	0.000429	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—ovarian cancer	0.000121	0.000428	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—ovarian cancer	0.000121	0.000427	CcSEcCtD
Propafenone—Flushing—Epirubicin—ovarian cancer	0.00012	0.000426	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—ovarian cancer	0.00012	0.000426	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—ovarian cancer	0.00012	0.000426	CcSEcCtD
Propafenone—Dyspepsia—Docetaxel—ovarian cancer	0.00012	0.000426	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—ovarian cancer	0.00012	0.000425	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—ovarian cancer	0.00012	0.000425	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000119	0.000423	CcSEcCtD
Propafenone—Decreased appetite—Docetaxel—ovarian cancer	0.000119	0.00042	CcSEcCtD
Propafenone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000119	0.00042	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000118	0.000419	CcSEcCtD
Propafenone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000118	0.000417	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000118	0.000417	CcSEcCtD
Propafenone—Fatigue—Docetaxel—ovarian cancer	0.000118	0.000417	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—ovarian cancer	0.000118	0.000416	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—ovarian cancer	0.000118	0.000416	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—ovarian cancer	0.000117	0.000415	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000117	0.000414	CcSEcCtD
Propafenone—Pain—Docetaxel—ovarian cancer	0.000117	0.000413	CcSEcCtD
Propafenone—Constipation—Docetaxel—ovarian cancer	0.000117	0.000413	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—ovarian cancer	0.000116	0.00041	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—ovarian cancer	0.000116	0.000409	CcSEcCtD
Propafenone—Asthenia—Paclitaxel—ovarian cancer	0.000116	0.000409	CcSEcCtD
Propafenone—Alopecia—Epirubicin—ovarian cancer	0.000115	0.000406	CcSEcCtD
Propafenone—Pruritus—Paclitaxel—ovarian cancer	0.000114	0.000404	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—ovarian cancer	0.000114	0.000402	CcSEcCtD
Propafenone—Erythema—Epirubicin—ovarian cancer	0.000113	0.0004	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—ovarian cancer	0.000113	0.0004	CcSEcCtD
Propafenone—Feeling abnormal—Docetaxel—ovarian cancer	0.000112	0.000398	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—ovarian cancer	0.000112	0.000397	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—ovarian cancer	0.000112	0.000396	CcSEcCtD
Propafenone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000112	0.000395	CcSEcCtD
Propafenone—Flushing—Doxorubicin—ovarian cancer	0.000111	0.000394	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000111	0.000394	CcSEcCtD
Propafenone—Flatulence—Epirubicin—ovarian cancer	0.000111	0.000394	CcSEcCtD
Propafenone—Tension—Epirubicin—ovarian cancer	0.000111	0.000392	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—ovarian cancer	0.00011	0.000391	CcSEcCtD
Propafenone—Diarrhoea—Paclitaxel—ovarian cancer	0.00011	0.00039	CcSEcCtD
Propafenone—Nervousness—Epirubicin—ovarian cancer	0.00011	0.000388	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—ovarian cancer	0.000109	0.000385	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—ovarian cancer	0.000108	0.000384	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—ovarian cancer	0.000108	0.000384	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000108	0.000383	CcSEcCtD
Propafenone—Abdominal pain—Docetaxel—ovarian cancer	0.000108	0.000382	CcSEcCtD
Propafenone—Body temperature increased—Docetaxel—ovarian cancer	0.000108	0.000382	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—ovarian cancer	0.000107	0.000379	CcSEcCtD
Propafenone—Dizziness—Paclitaxel—ovarian cancer	0.000107	0.000377	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—ovarian cancer	0.000106	0.000377	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—ovarian cancer	0.000106	0.000375	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—ovarian cancer	0.000105	0.000372	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000105	0.000371	CcSEcCtD
Propafenone—Erythema—Doxorubicin—ovarian cancer	0.000104	0.00037	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—ovarian cancer	0.000104	0.00037	CcSEcCtD
Propafenone—Anaemia—Epirubicin—ovarian cancer	0.000104	0.000369	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—ovarian cancer	0.000103	0.000364	CcSEcCtD
Propafenone—Tension—Doxorubicin—ovarian cancer	0.000102	0.000363	CcSEcCtD
Propafenone—Vomiting—Paclitaxel—ovarian cancer	0.000102	0.000363	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—ovarian cancer	0.000102	0.000362	CcSEcCtD
Propafenone—Malaise—Epirubicin—ovarian cancer	0.000102	0.00036	CcSEcCtD
Propafenone—Rash—Paclitaxel—ovarian cancer	0.000102	0.00036	CcSEcCtD
Propafenone—Dermatitis—Paclitaxel—ovarian cancer	0.000101	0.000359	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—ovarian cancer	0.000101	0.000359	CcSEcCtD
Propafenone—Vertigo—Epirubicin—ovarian cancer	0.000101	0.000359	CcSEcCtD
Propafenone—Syncope—Epirubicin—ovarian cancer	0.000101	0.000358	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—ovarian cancer	0.000101	0.000358	CcSEcCtD
Propafenone—Headache—Paclitaxel—ovarian cancer	0.000101	0.000357	CcSEcCtD
Propafenone—Hypersensitivity—Docetaxel—ovarian cancer	0.000101	0.000356	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—ovarian cancer	0.0001	0.000355	CcSEcCtD
Propafenone—Palpitations—Epirubicin—ovarian cancer	9.97e-05	0.000353	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—ovarian cancer	9.92e-05	0.000351	CcSEcCtD
Propafenone—Cough—Epirubicin—ovarian cancer	9.85e-05	0.000349	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—ovarian cancer	9.84e-05	0.000348	CcSEcCtD
Propafenone—Asthenia—Docetaxel—ovarian cancer	9.79e-05	0.000347	CcSEcCtD
Propafenone—Convulsion—Epirubicin—ovarian cancer	9.78e-05	0.000346	CcSEcCtD
Propafenone—Hypertension—Epirubicin—ovarian cancer	9.74e-05	0.000345	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—ovarian cancer	9.69e-05	0.000343	CcSEcCtD
Propafenone—Pruritus—Docetaxel—ovarian cancer	9.66e-05	0.000342	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—ovarian cancer	9.65e-05	0.000342	CcSEcCtD
Propafenone—Myalgia—Epirubicin—ovarian cancer	9.61e-05	0.00034	CcSEcCtD
Propafenone—Chest pain—Epirubicin—ovarian cancer	9.61e-05	0.00034	CcSEcCtD
Propafenone—Anxiety—Epirubicin—ovarian cancer	9.57e-05	0.000339	CcSEcCtD
Propafenone—Nausea—Paclitaxel—ovarian cancer	9.57e-05	0.000339	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	9.54e-05	0.000338	CcSEcCtD
Propafenone—Discomfort—Epirubicin—ovarian cancer	9.49e-05	0.000336	CcSEcCtD
Propafenone—Malaise—Doxorubicin—ovarian cancer	9.41e-05	0.000333	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—ovarian cancer	9.39e-05	0.000333	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—ovarian cancer	9.38e-05	0.000332	CcSEcCtD
Propafenone—Syncope—Doxorubicin—ovarian cancer	9.36e-05	0.000332	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—ovarian cancer	9.34e-05	0.000331	CcSEcCtD
Propafenone—Diarrhoea—Docetaxel—ovarian cancer	9.34e-05	0.000331	CcSEcCtD
Propafenone—Confusional state—Epirubicin—ovarian cancer	9.28e-05	0.000329	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—ovarian cancer	9.23e-05	0.000327	CcSEcCtD
Propafenone—Oedema—Epirubicin—ovarian cancer	9.21e-05	0.000326	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—ovarian cancer	9.18e-05	0.000325	CcSEcCtD
Propafenone—Infection—Epirubicin—ovarian cancer	9.15e-05	0.000324	CcSEcCtD
Propafenone—Cough—Doxorubicin—ovarian cancer	9.11e-05	0.000323	CcSEcCtD
Propafenone—Shock—Epirubicin—ovarian cancer	9.06e-05	0.000321	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—ovarian cancer	9.04e-05	0.00032	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—ovarian cancer	9.03e-05	0.00032	CcSEcCtD
Propafenone—Dizziness—Docetaxel—ovarian cancer	9.03e-05	0.00032	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—ovarian cancer	9.02e-05	0.000319	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—ovarian cancer	9.01e-05	0.000319	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—ovarian cancer	8.99e-05	0.000318	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—ovarian cancer	8.94e-05	0.000317	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—ovarian cancer	8.9e-05	0.000315	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—ovarian cancer	8.89e-05	0.000315	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—ovarian cancer	8.89e-05	0.000315	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—ovarian cancer	8.86e-05	0.000314	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	8.83e-05	0.000313	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—ovarian cancer	8.78e-05	0.000311	CcSEcCtD
Propafenone—Anorexia—Epirubicin—ovarian cancer	8.78e-05	0.000311	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—ovarian cancer	8.69e-05	0.000308	CcSEcCtD
Propafenone—Vomiting—Docetaxel—ovarian cancer	8.68e-05	0.000307	CcSEcCtD
Propafenone—Rash—Docetaxel—ovarian cancer	8.61e-05	0.000305	CcSEcCtD
Propafenone—Hypotension—Epirubicin—ovarian cancer	8.6e-05	0.000305	CcSEcCtD
Propafenone—Dermatitis—Docetaxel—ovarian cancer	8.6e-05	0.000305	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—ovarian cancer	8.59e-05	0.000304	CcSEcCtD
Propafenone—Headache—Docetaxel—ovarian cancer	8.55e-05	0.000303	CcSEcCtD
Propafenone—Oedema—Doxorubicin—ovarian cancer	8.52e-05	0.000302	CcSEcCtD
Propafenone—Infection—Doxorubicin—ovarian cancer	8.46e-05	0.0003	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.39e-05	0.000297	CcSEcCtD
Propafenone—Shock—Doxorubicin—ovarian cancer	8.38e-05	0.000297	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—ovarian cancer	8.36e-05	0.000296	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—ovarian cancer	8.34e-05	0.000295	CcSEcCtD
Propafenone—Insomnia—Epirubicin—ovarian cancer	8.33e-05	0.000295	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—ovarian cancer	8.32e-05	0.000294	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—ovarian cancer	8.28e-05	0.000293	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—ovarian cancer	8.27e-05	0.000293	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—ovarian cancer	8.24e-05	0.000292	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—ovarian cancer	8.21e-05	0.000291	CcSEcCtD
Propafenone—Somnolence—Epirubicin—ovarian cancer	8.19e-05	0.00029	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—ovarian cancer	8.12e-05	0.000288	CcSEcCtD
Propafenone—Nausea—Docetaxel—ovarian cancer	8.11e-05	0.000287	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—ovarian cancer	8.11e-05	0.000287	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—ovarian cancer	8e-05	0.000283	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—ovarian cancer	7.96e-05	0.000282	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.95e-05	0.000282	CcSEcCtD
Propafenone—Fatigue—Epirubicin—ovarian cancer	7.94e-05	0.000281	CcSEcCtD
Propafenone—Pain—Epirubicin—ovarian cancer	7.87e-05	0.000279	CcSEcCtD
Propafenone—Constipation—Epirubicin—ovarian cancer	7.87e-05	0.000279	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.76e-05	0.000275	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—ovarian cancer	7.71e-05	0.000273	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—ovarian cancer	7.65e-05	0.000271	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—ovarian cancer	7.6e-05	0.000269	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—ovarian cancer	7.59e-05	0.000269	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—ovarian cancer	7.57e-05	0.000268	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—ovarian cancer	7.53e-05	0.000267	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—ovarian cancer	7.5e-05	0.000266	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—ovarian cancer	7.41e-05	0.000262	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.36e-05	0.000261	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—ovarian cancer	7.35e-05	0.00026	CcSEcCtD
Propafenone—Urticaria—Epirubicin—ovarian cancer	7.31e-05	0.000259	CcSEcCtD
Propafenone—Constipation—Doxorubicin—ovarian cancer	7.29e-05	0.000258	CcSEcCtD
Propafenone—Pain—Doxorubicin—ovarian cancer	7.29e-05	0.000258	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—ovarian cancer	7.28e-05	0.000258	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—ovarian cancer	7.28e-05	0.000258	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—ovarian cancer	7.02e-05	0.000249	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.97e-05	0.000247	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—ovarian cancer	6.78e-05	0.00024	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—ovarian cancer	6.77e-05	0.00024	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—ovarian cancer	6.74e-05	0.000239	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—ovarian cancer	6.74e-05	0.000239	CcSEcCtD
Propafenone—Asthenia—Epirubicin—ovarian cancer	6.61e-05	0.000234	CcSEcCtD
Propafenone—Pruritus—Epirubicin—ovarian cancer	6.51e-05	0.000231	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—ovarian cancer	6.3e-05	0.000223	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—ovarian cancer	6.28e-05	0.000222	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—ovarian cancer	6.11e-05	0.000216	CcSEcCtD
Propafenone—Dizziness—Epirubicin—ovarian cancer	6.09e-05	0.000216	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—ovarian cancer	6.03e-05	0.000213	CcSEcCtD
Propafenone—Vomiting—Epirubicin—ovarian cancer	5.85e-05	0.000207	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—ovarian cancer	5.83e-05	0.000206	CcSEcCtD
Propafenone—Rash—Epirubicin—ovarian cancer	5.81e-05	0.000206	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—ovarian cancer	5.8e-05	0.000205	CcSEcCtD
Propafenone—Headache—Epirubicin—ovarian cancer	5.77e-05	0.000204	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—ovarian cancer	5.63e-05	0.0002	CcSEcCtD
Propafenone—Nausea—Epirubicin—ovarian cancer	5.47e-05	0.000194	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—ovarian cancer	5.42e-05	0.000192	CcSEcCtD
Propafenone—Rash—Doxorubicin—ovarian cancer	5.37e-05	0.00019	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—ovarian cancer	5.37e-05	0.00019	CcSEcCtD
Propafenone—Headache—Doxorubicin—ovarian cancer	5.34e-05	0.000189	CcSEcCtD
Propafenone—Nausea—Doxorubicin—ovarian cancer	5.06e-05	0.000179	CcSEcCtD
